Caroline Breitbach

Caroline Breitbach has an extensive work experience in the biotechnology and pharmaceutical industry. Caroline is currently the Senior Vice President of Asset & Portfolio Leadership at Mariana Oncology, a position they started in 2023. Prior to this, they were the President of Cadeos Biotherapeutics Consulting since 2014.

From 2021 to 2023, Caroline held two roles at SpringWorks Therapeutics, including Senior Vice President of Global Disease Area Lead and Senior Vice President of Early Development Programs.

Before joining SpringWorks Therapeutics, they worked at Turnstone Biologics, starting as the Vice President of Translational Development from 2015 to 2018. Caroline then became the Vice President of R&D Programs and Strategy until 2021. During their time at Turnstone Biologics, Caroline guided the company's R&D strategy and led multiple programs in the field of immunotherapy and cell therapy.

From 2014 to 2015, Caroline served as the Vice President of Clinical & Translational Research at SillaJen Inc. Prior to that, they worked at Jennerex Biotherapeutics in various roles, including Senior Director of Clinical & Translational Research, Associate Director of Clinical Research, and Clinical Research Fellow.

Caroline Breitbach's work experience demonstrates their expertise in leadership, strategy development, and clinical research within the biotechnology and pharmaceutical industry.

Caroline Breitbach earned an Hon. BSc in Microbiology & Immunology from McGill University from 2000 to 2003. Caroline then pursued a PhD in Biochemistry at the University of Ottawa from 2004 to 2009. In 2011, they attended the University of California, Berkeley, Haas School of Business for the Center for Executive Education, though their specific degree is not mentioned.